StageSeed - II | Alive
Last Raised$1.13M | 1 yr ago
Missing: XVision's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: XVision's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing XVision
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
XVision is included in 4 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Health Monitoring & Diagnostics
Companies developing technology for computer-aided diagnostic imaging. Companies tagged as #ComputerAidedDxImaging
Latest XVision News
Mar 8, 2023
CHICAGO--(BUSINESS WIRE)-- #augmentedreality--Augmedics launches FDA-cleared AI features and new spinal indications in expansion of its xvision augmented reality surgical navigation system
XVision Frequently Asked Questions (FAQ)
What is XVision's latest funding round?
XVision's latest funding round is Seed - II.
How much did XVision raise?
XVision raised a total of $1.16M.
Who are the investors of XVision?
Investors of XVision include Gap Minder, Growceanu Angel Investment, ResQMed, Marek Dziubinski, Cristian Pop and 7 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.